Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
0.4421
-0.0249 (-5.33%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Lyell Immunopharma Market Cap
Lyell Immunopharma has a market cap or net worth of $132.96 million as of April 25, 2025. Its market cap has decreased by -78.64% in one year.
Market Cap
132.96M
Enterprise Value
-191.61M
1-Year Change
-78.64%
Ranking
Category
Stock Price
$0.44
Market Cap Chart
Since the IPO on June 17, 2021, Lyell Immunopharma's market cap has decreased from $4.13B to $132.96M, a decrease of -96.78%. That is a compound annual growth rate of -58.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 132.96M | -28.89% |
| Dec 31, 2024 | 186.98M | -61.73% |
| Dec 29, 2023 | 488.63M | -43.52% |
| Dec 30, 2022 | 865.16M | -53.52% |
| Dec 31, 2021 | 1.86B | -54.91% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.03B |
| UnitedHealth Group | 386.16B |
| Johnson & Johnson | 372.77B |
| AbbVie | 319.07B |
| Novo Nordisk | 276.96B |
| Abbott Laboratories | 224.39B |
| AstraZeneca | 215.41B |
| Novartis AG | 210.89B |